December 20, 2024
Free initial consultations are available only with select providers
After a licensed-provider evaluation by an independent network of US-licensed providers, a provider will assess whether semaglutide may be appropriate based on your full health picture
COMES OUT TO JUST OVER $3/DAY
In the 2021 STEP-1 trial (1,961 adults with obesity or overweight), participants receiving semaglutide plus lifestyle intervention experienced a 14.9% mean weight loss after 68 weeks, while those on placebo lost only 2.4%
Based on published phase 2 clinical trial data, the most commonly reported adverse effects include: Gastrointestinal effects: Nausea, vomiting, diarrhoea, constipation, and reduced appetite are the most frequently reported side effects